Safety profile of letrozole in the real world: a disproportionality analysis of FAERS database and systematic review of case reports

Clinicians need to pay attention to rhabdomyolysis when letrozole combined with catecholaminergic agents. Patient education on urine output monitoring is essential due to potential kidney injury. Bone marrow suppression and reproductive toxicity risks require clinical attention.